Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133712) titled 'Clinical Application of ^68Ga-ZB7-H3 PET Imaging in the Diagnosis and Management of Solid Tumors' on Sept. 30.
Study Type: Diagnostic test
Study Design:
Sequential
Primary Sponsor: The First Hospital of China Medical University
Condition:
Malignant tumor
Intervention:
Gold Standard:18F-FDG/PSMA PET or Pathology
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target Sample Size: Target condition:58;Difficult condition:2
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343730
Published by HT Digital Content Services ...